Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats. - Wikidata - wikimedia - TriplyDB

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

http://www.wikidata.org/entity/Q33621097

about

Neuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responses Role of kappa-opioid receptors in stress and anxiety-related behavior.The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist Sexual dimorphism in locus coeruleus dendritic morphology: a structural basis for sex differences in emotional arousal Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology Novel molecular targets of dezocine and their clinical implications Avoidance expression in rats as a function of signal-shock interval: strain and sex differences Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility.Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse Attenuated inhibition of medium spiny neurons participates in the pathogenesis of childhood depression.Sex differences in kappa opioid pharmacology Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects.Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats.Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors.A role for the mu opioid receptor in the antidepressant effects of buprenorphine.The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in rats Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.Antidepressant-like effects of buprenorphine in rats are strain dependent.Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.Inflammatory Factors Mediate Vulnerability to a Social Stress-Induced Depressive-like Phenotype in Passive Coping Rats.Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment.Dysfunctional inhibitory mechanisms in locus coeruleus neurons of the wistar kyoto rat.Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats.Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.Chromatin alterations in response to forced swimming underlie increased prodynorphin transcription Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level Conceptualizing withdrawal-induced escalation of alcohol self-administration as a learned, plasticity-dependent process.Development of κ opioid receptor antagonists.Naltrexone alters the processing of social and emotional stimuli in healthy adults Psychopharmacologic treatment of borderline personality disorder.A large-scale candidate gene analysis of mood disorders: evidence of neurotrophic tyrosine kinase receptor and opioid receptor signaling dysfunction.The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.

P2860

Q26830264-0A1B6908-DC2D-4E72-BC53-C8BF3E1A0A8A Q26991739-90C449D7-1F96-4D1E-BDF5-9F097BEEE26B Q28243936-D92923E3-5DBB-4ED4-98F8-11B8001758CE Q28578768-44C00612-AC17-43AC-B791-1CA2D0B1B8CC Q28583583-EC940B83-E9A6-4220-A384-20D83E415DDF Q28658148-D9ECACBF-8EAC-45B4-8191-6B507BBC8E32 Q30406250-542244D5-932C-4F7D-A25B-4DD7CF3ECE81 Q30442231-961E6D24-6CE7-471E-83BC-5007E5A5DE70 Q30459620-DEC00EBD-A60B-4CAA-9FD5-614D892DB4FC Q33728962-703D8702-DC9C-4D1C-B53B-D9C82625A508 Q33847097-B25E501C-7D63-42B4-9150-41FB97447AF6 Q33890721-3240B9CE-8F74-47E0-8B40-0B365387F846 Q34096263-B59830E6-1950-4890-8A3D-2BB4261C1731 Q34144003-EA753497-D1BC-49EB-865D-0617C16480DD Q34409641-D9BB3486-DAF0-4220-AC63-9D00AE844995 Q34436340-23CAC9D7-29AC-4575-A24A-2D288ACEE43C Q34482680-2670DF3F-1CA7-44D6-A388-FE283BC98BA8 Q34518271-024E382F-A4B0-4206-BFB6-9D7D4CA600B9 Q34544184-6C622B51-5581-4F80-9CBB-E3E8298DDB9F Q34553463-336DEA0D-17FF-4602-B79B-3F5A1F4D1157 Q35016982-C42286FE-AE15-4719-AD11-8C477872011B Q35067118-3ABBEAFA-7559-4B94-90A2-6F50EE4F5AAC Q35147542-08560B77-C5AB-4ACD-BBC0-4AD572884290 Q35243233-DC0F5F29-E5D0-4F2D-8418-E7FFC6117B00 Q35429559-A6B5E175-381F-4F02-BAE8-52F04E116281 Q35642528-A1B36D41-7F86-4C88-9A85-4EA62B9413C3 Q35736840-EA002993-7D98-44BA-B2FC-3B1BD9E8FC19 Q35965863-5F63DD37-6BB5-4243-9760-BBCA75C377E6 Q36017518-8CAB1D81-B77B-4F2A-B552-8B5DB32C5082 Q36092808-DC651D03-3FAA-4105-99A8-004F551C0168 Q36143981-9597AFEF-E182-4BC4-A778-110B94025E52 Q36223676-E2060372-788F-45B7-87A6-BC5ED3766F8E Q36644242-319FD485-9A4D-45A2-B581-B1D8B3E3941A Q36728154-DE2F7FAC-73E0-41AD-9E7F-C3240545DC00 Q37119755-F0057908-8AA8-4814-A051-50243CA3D49E Q37262938-D68B84AF-0964-4E66-9821-0E71FD3ED58A Q37407150-A8D4B341-DB1D-4CA6-B832-5EE1E466DE4D Q37946259-B33E9F44-C503-4E0A-A6CD-FC6B885CEBC9 Q38373652-5392EE90-A133-41AF-A808-07D97DA0316A Q38543238-530696E8-7235-4A6D-83CF-72E234DB41DA

P2860

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

http://www.wikidata.org/entity/Q33621097

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@ast

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@en

type

label

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@ast

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@en

prefLabel

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@ast

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@en

P1433

Q33621097-60AB2F73-82A3-4CAD-BE6C-9DFCCCF17034

P1476

Q33621097-ECF79F65-9019-4B61-8FE3-74A18CDF876C

P2093

Q33621097-55589003-6FA9-47F6-A2F2-B1B1EDFA7BAA

Q33621097-C2F06F6E-E79A-4A8C-8980-A14CAC7C282A

Q33621097-F3820D72-1788-440A-B269-40BFC6FEFA1F

Q33621097-FF9421FC-5A47-4098-AD17-F6A45BC19B90

P2860

Q33621097-0BBEECB6-CA6B-4FA6-957E-15786B896AF9

Q33621097-14A6C654-34D5-467F-9047-76381107B879

Q33621097-14C10AB7-2668-405C-A084-6102E718B175

Q33621097-15BE5FDF-BE3B-4701-ACE4-33C03E7AD8DA

Q33621097-194D2B1B-8A2F-443F-BF9B-DFFA3C19F3BC

Q33621097-1C19C76A-56B1-4665-A89A-3D9132A0B0C6

Q33621097-1C335496-DF00-4B72-87E3-9FE755751F16

Q33621097-311BFDD7-F9EC-437A-A4BE-1FEF3A76DA1E

Q33621097-3249D462-EAFA-484D-9A9E-6B5294341358

Q33621097-396517A4-1BB8-4BA4-84E0-17C336FD0233

P2888

Q33621097-47485DF7-36DD-462D-8959-E0959DB879C1

P304

Q33621097-4931C3ED-2AEA-4CD4-AEB1-F6A6286C8485

P31

Q33621097-7B802A7B-BA10-473F-AA60-F2C31BB8D4E9

P356

Q33621097-EEAA8C72-1487-4BD1-84CB-2B65BD900F67

P407

Q33621097-432E1D4A-3637-428D-AFA0-6013497BFC7F

P433

Q33621097-1F33CA81-D9F7-4FD7-87D9-975A9F3B19A5

P478

Q33621097-0188C68B-299D-44A9-8BC2-310EEF77EC65

P50

Q33621097-934C05A4-341F-4970-BFC2-0034900EB2B1

Q33621097-ED62AF77-195E-4CF0-8560-854D84B7437A

P577

Q33621097-601AEBD7-B166-4496-AC7F-0131BD925459

P5875

Q33621097-59DCDAA4-889A-43A1-8D05-5FD55AB78378

P6179

Q33621097-6F2DFBAF-167A-4991-AC7E-BAA3E95F1191

P698

Q33621097-E894EBD7-A192-48EF-8B2B-90264970C922

P921

Q33621097-4937e5bb-4f18-482f-a98d-1d8579efff0f

P932

Q33621097-AE1073D9-AAAC-4361-B2F1-65CBBE6CD7FC

P356

P1433

Neuropsychopharmacology

P1476

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

@en

P2093

Debra A Bangasser

http://www.w3.org/2001/XMLSchema#string

Irwin Lucki

http://www.w3.org/2001/XMLSchema#string

Matthew Young

http://www.w3.org/2001/XMLSchema#string

Thelma Bethea

http://www.w3.org/2001/XMLSchema#string

P2860

The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system

Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses

Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system

Development of a strain of spontaneously hypertensive rats

The use of c-fos as a metabolic marker in neuronal pathway tracing

2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl]acetamide: an opioid receptor affinity label that produces selective and long-lasting kappa antagonism in mice

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

P2888

P304

752-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2009.183

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Rita J. Valentino

P577

2009-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38099843

http://www.w3.org/2001/XMLSchema#string

P6179

1032426394

http://www.w3.org/2001/XMLSchema#string

P698

19924112

http://www.w3.org/2001/XMLSchema#string

P921

P932

2813986

http://www.w3.org/2001/XMLSchema#string